SCHEMBL932093

SCHEMBL932093

Cc1cc(C(=N)c2cccc(Br)c2)cc(C)n1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
C1S P09871 1/20 0.50
TSHR P16473 1/20 0.49
NPSR1 Q6W5P4 1/20 0.49
GRM5 P41594 1/20 0.47
PARP1 P09874 1/20 0.42
PLAU P00749 1/20 0.40
ALDH1A1 P00352 2/20 0.39
MAPK1 P28482 1/20 0.39
NPC1 O15118 2/20 0.38
RAB9A P51151 2/20 0.38
ATM Q13315 1/20 0.38
ABCB1 P08183 1/20 0.38
ABCC1 P33527 1/20 0.38
ABCG2 Q9UNQ0 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
TP53 P04637 1/20 0.38
HCRTR1 O43613 1/20 0.36
CASP3 P42574 1/20 0.36
SENP8 Q96LD8 1/20 0.36
SENP7 Q9BQF6 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4782738 0.79 TSHR (0.56) C1STSHRNPSR1GRM5PARP1
SCHEMBL18540679 0.77 C1S (0.55) C1STSHRPARP1ALDH1A1NPC1
SCHEMBL931729 0.76 C1S (0.46) C1STSHRNPSR1PARP1PLAU
SCHEMBL932511 0.75 C1S (0.53) C1STSHRNPSR1PARP1ALDH1A1
SCHEMBL18540642 0.75 PRSS1 (0.49) C1SPARP1MAPK1NPC1RAB9A
SCHEMBL18540697 0.74 C1S (0.57) C1STSHRPARP1ALDH1A1NPC1
SCHEMBL931934 0.73 C1S (0.47) C1STSHRNPSR1GRM5PARP1
SCHEMBL931503 0.71 C1S (0.53) C1SPARP1ALDH1A1ATMTP53
SCHEMBL3178752 0.71 C1S (0.63) C1STSHRNPSR1PARP1ALDH1A1
SCHEMBL931923 0.71 C1S (0.49) C1SNPSR1PARP1ALDH1A1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011002407-A1 NOVEL COMPOUNDS FOR TREATMENT OF NEURODEGENERATION ASSOCIATED WITH DISEASES, SUCH AS ALZHEIMER'S DISEASE OR DEMENTIA ASTRAZENECA AB (SE) 2011-01-06 WO disclosed
WO-2011002407-A1 NOVEL COMPOUNDS FOR TREATMENT OF NEURODEGENERATION ASSOCIATED WITH DISEASES, SUCH AS ALZHEIMER'S DISEASE OR DEMENTIA ASTRAZENECA AB (SE) 2011-01-06 WO disclosed